97 related articles for article (PubMed ID: 15482860)
1. Histone acetyltransferase activity of p300 enhances the activation of IL-12 p40 promoter.
Sun H; Lu J; Wei L; Wang X; Xu X; Dong M; Huang B
Mol Immunol; 2004 Nov; 41(12):1241-6. PubMed ID: 15482860
[TBL] [Abstract][Full Text] [Related]
2. Histone acetyltransferase activity of p300 enhances the activation of IL-18 promoter.
Sun H; Lu J; Xu X; Jin S; Wang X; Wei L; Dong M; Huang B
J Cell Biochem; 2005 Feb; 94(3):566-72. PubMed ID: 15543578
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDAC1 and p300.
Lu J; Sun H; Wang X; Liu C; Xu X; Li F; Huang B
Cytokine; 2005 Jul; 31(1):46-51. PubMed ID: 15869883
[TBL] [Abstract][Full Text] [Related]
4. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1.
Liu C; Lu J; Tan J; Li L; Huang B
Cytokine; 2004 Aug 21-Sep 7; 27(4-5):93-100. PubMed ID: 15271374
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
7. Histone acetyltransferase p300 promotes the activation of human WT1 promoter and intronic enhancer.
Shao Y; Lu J; Zhang G; Liu C; Huang B
Arch Biochem Biophys; 2005 Apr; 436(1):62-8. PubMed ID: 15752709
[TBL] [Abstract][Full Text] [Related]
8. p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.
Debes JD; Schmidt LJ; Huang H; Tindall DJ
Cancer Res; 2002 Oct; 62(20):5632-6. PubMed ID: 12384515
[TBL] [Abstract][Full Text] [Related]
9. Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1.
Lee JH; Volinic JL; Banz C; Yao KM; Thomas MK
J Endocrinol; 2005 Nov; 187(2):283-92. PubMed ID: 16293776
[TBL] [Abstract][Full Text] [Related]
10. Transcription factors Ets2 and Sp1 act synergistically with histone acetyltransferase p300 in activating human interleukin-12 p40 promoter.
Sun HJ; Xu X; Wang XL; Wei L; Li F; Lu J; Huang BQ
Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):194-200. PubMed ID: 16518544
[TBL] [Abstract][Full Text] [Related]
11. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
12. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition.
Ait-Si-Ali S; Polesskaya A; Filleur S; Ferreira R; Duquet A; Robin P; Vervish A; Trouche D; Cabon F; Harel-Bellan A
Oncogene; 2000 May; 19(20):2430-7. PubMed ID: 10828885
[TBL] [Abstract][Full Text] [Related]
13. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
15. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.
Becker C; Wirtz S; Blessing M; Pirhonen J; Strand D; Bechthold O; Frick J; Galle PR; Autenrieth I; Neurath MF
J Clin Invest; 2003 Sep; 112(5):693-706. PubMed ID: 12952918
[TBL] [Abstract][Full Text] [Related]
16. Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cells.
Chambers KA; Parks RJ; Angel JB
Clin Exp Immunol; 2004 Aug; 137(2):329-40. PubMed ID: 15270850
[TBL] [Abstract][Full Text] [Related]
17. IL-4 regulates IL-12 p40 expression post-transcriptionally as well as via a promoter-based mechanism.
Seegmüller I; Häcker H; Wagner H
Eur J Immunol; 2003 Feb; 33(2):428-33. PubMed ID: 12645940
[TBL] [Abstract][Full Text] [Related]
18. Targeting of a histone acetyltransferase domain to a promoter enhances protein expression levels in mammalian cells.
Kwaks TH; Sewalt RG; van Blokland R; Siersma TJ; Kasiem M; Kelder A; Otte AP
J Biotechnol; 2005 Jan; 115(1):35-46. PubMed ID: 15607223
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of cytosolic alanine aminotransferase gene promoter by p300 and c-Myb.
Anemaet IG; González JD; Salgado MC; Giralt M; Fernández F; Baanante IV; Metón I
J Mol Endocrinol; 2010 Sep; 45(3):119-32. PubMed ID: 20573775
[TBL] [Abstract][Full Text] [Related]
20. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
